Eiken Chemical Co., Ltd. (TYO:4549)

Market Cap	74.30B
Revenue (ttm)	40.20B
Net Income (ttm)	2.18B
Shares Out	33.68M
EPS (ttm)	61.98
PE Ratio	35.59
Forward PE	22.93
Dividend	54.00 (2.44%)
Ex-Dividend Date	Mar 28, 2025

Volume	26,800
Average Volume	86,925
Open	2,228.00
Previous Close	2,210.00
Day's Range	2,203.00 - 2,254.00
52-Week Range	1,849.00 - 2,568.00
Beta	0.17
RSI	49.21
Earnings Date	May 13, 2025

About Eiken Chemical

Eiken Chemical Co., Ltd. engages in the manufacturing and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer. The company also provides immunological and serological reagents to detect and monitor infectious disease, rheumatism, inflammation, atrophic gastritis, and prostate...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1939
• Employees: 757
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4549

Financial Performance

In 2023, Eiken Chemical's revenue was 40.05 billion, a decrease of -7.44% compared to the previous year's 43.27 billion. Earnings were 2.63 billion, a decrease of -54.08%.